Filing Details

Accession Number:
0001651308-23-000006
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-11 16:50:36
Reporting Period:
2023-01-09
Accepted Time:
2023-01-11 16:50:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1651308 Beigene Ltd. BGNE Pharmaceutical Preparations (2834) 981209416
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1662982 Xiaodong Wang C/O Mourant Governance Services (Cayman)
94 Solaris Avenue
Camana Bay, Grand Cayman E9 KY1-1108
Yes No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
American Depositary Shares Disposition 2023-01-09 900 $250.00 0 No 4 S Direct
American Depositary Shares Disposition 2023-01-10 1,600 $250.09 0 No 4 S Direct
American Depositary Shares Disposition 2023-01-11 200 $250.39 2,300 No 4 S Direct
American Depositary Shares Disposition 2023-01-11 1,250 $252.22 1,050 No 4 S Direct
American Depositary Shares Disposition 2023-01-11 950 $253.57 100 No 4 S Direct
American Depositary Shares Disposition 2023-01-11 100 $254.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 5,512,556 Direct
Ordinary Shares 1,127,542 Indirect See Footnote
Ordinary Shares 172,372 Indirect See Footnote
Ordinary Shares 4,123,998 Indirect See Footnote
Ordinary Shares 50 Indirect See Footnote
Footnotes
  1. These securities are held by a family trust, the beneficiaries of which are the Reporting Person's family members, for which the Reporting Person disclaims beneficial ownership.
  2. These securities are held in a UTMA account for the Reporting Person's minor child, for which the Reporting Person disclaims beneficial ownership.
  3. These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership.
  4. These securities are held by the spouse of the Reporting Person.
  5. Each American Depositary Share represents 13 Ordinary Shares.
  6. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2021, as most recently amended on June 15, 2022.
  7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.00 to $250.26, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
  8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.08 to $251.02, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
  9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.00 to $252.56, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
  10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.00 to $253.66, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.